WikiLeaks, Kraft, Rolex, Google: Intellectual Property

Access to cheaper drugs in other countries may be limited by a provision sought by the U.S. in a Pacific trade deal, according to patent specialists who reviewed a document exposed by the WikiLeaks anti-secrecy group.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.